From: Pathways to psychiatric care in urban north China: a general hospital based study
CCMD-3 diagnostic group | Male | Female | χ2 | df | P |
---|---|---|---|---|---|
 | n (%) | n (%) |  |  |  |
Depression (F32.0) | 27 (32.9) | 55 (67.1) | 9.56 | 1 | 0.002 |
Neurosis (F40-F49) | 37 (36.3) | 65 (63.7) | 7.69 | 1 | 0.006 |
Anxiety (F41+ F41.1) | 17 (48.6) | 18 (51.4) | 0 03 | 1 | 0.866 |
Somatoform disorders (F45) | 23 (42.6) | 31 (57.4) | 1 185 | 1 | 0.276 |
Neurasthenia (F48.0) | 3 (18.8) | 13 (81.3) | 6.25 | 1 | 0.012 |
Organic mental disorders (F00 + F01) | 5 (16.7) | 25 (83.3) | 13.33 | 1 | <0.001 |
Insomnia (F51.0) | 8 (30.8) | 18 (69.2) | 3846 | 1 | 0.05 |
Schizophreniaa (F20) | 4 (80.0) | 1 (25.0) | Â | Â | Â |
Bipolar disorders (F31) | 4 (30.8) | 9 (69.2) | 1.923 | 1 | 0.166 |
Status of depression and anxiety | 32 (41.6) | 45 (58.4) | 2.20 | 1 | 0.138 |
Hysterical psychological disordersa (F44.8) | 0 | 1 (100) | Â | Â | Â |
Total | 160 | 281 | Â | Â | Â |